Evidence map›Paper›PMID 28186949›Full record

Trial reportBMJ open2016

Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention.

Stefan Lönnberg, Trude Andreassen, Birgit Engesæter, Rune Lilleng, Cecilia Kleven, Annelie Skare, Karin Johansson, Christina Stangeland Fredheim, Ameli Tropé

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Stefan LönnbergCancer Registry of Norway, Oslo, Norway.ORCID 0000-0002-5561-9041
Trude AndreassenCancer Registry of Norway, Oslo, Norway.
Birgit EngesæterCancer Registry of Norway, Oslo, Norway.
Rune LillengDepartment of Pathology, Vestre Viken Hospital Trust, Drammen, Norway.
Cecilia KlevenOslo Jordmor og Kvinnesenter AS, Oslo, Norway.
Annelie SkareOslo Jordmor og Kvinnesenter AS, Oslo, Norway.
Karin JohanssonOslo Jordmor og Kvinnesenter AS, Oslo, Norway.
Christina Stangeland FredheimKråkerøy Legesenter AS, Fredrikstad, Norway.
Ameli TropéCancer Registry of Norway, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe main barrier to optimal effect in many established population-based screening programmes against cervical cancer is low participation. In Norway, a routine health service integrated population-based screening programme has been running since 1995, using open invitations and reminders. The aim of this randomised health service study was to pilot scheduled appointments and assess their potential for increased participation.

methodsWithin the national screening programme, we randomised 1087 women overdue for screening to receive invitations with scheduled appointments (intervention) or the standard open reminders (control). Letters were sent 2-4 weeks before the scheduled appointments at three centres: a midwife clinic, a public healthcare centre and a general practitioner centre. The primary outcome was participation at 6 months of follow-up. Secondary outcomes were participation at 1 and 3 months. Risk ratios (RRs) overall, and stratified by screening centre, age group and previous participation, were calculated using log-binomial regression.

resultsAt 6 months, 20% of the 510 women in the control group and 37% of the 526 women in the intervention group had participated in screening, excluding 51 women in total from analysis due to participation just before invitation and therefore not yet visible in the central records. The RR for participation at 6 months was 1.9 (95% CI 1.5 to 2.3). There was no significant heterogeneity between centres or age groups. Participation increased among women both with (RR 1.7; 95% CI 1.4 to 2.1) and without (RR 3.5; 95% CI 1.3 to 9.2) previous participation. The RRs for participation at 1 and 3 months were 4.0 (95% CI 2.6 to 6.2) and 2.7 (95% CI 2.1 to 3.5), respectively.

conclusionsScheduled appointments increased screening participation consistently across all target ages and screening centres among women overdue for screening. Participation increased also among women with no previous records of cervical screening.

Indexed as

Appointments and SchedulesMass ScreeningAdultAgedEarly Detection of CancerFemaleFollow-Up StudiesHumansMiddle AgedNorwayPatient CompliancePilot ProjectsReminder SystemsTime FactorsUterine Cervical NeoplasmsPREVENTIVE MEDICINE

Identifiers

PMID28186949
PMCPMC5128903

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.